Cupid leading manufacturer of quality male and female condoms headquartered in Nashik, India. It has one of the largest manufacturing facilities and R&D center. In addition to Nashik, the Company has its marketing office in Mumbai .Cupid Ltd. is successfully manufacturing since 1998 and marketing condoms in India and over 26 countries around the world.

The Nashik-based company, in the western state of Maharashtra is primarily supplies condoms to governments and NGOs for their AIDS prevention and family planning programs. It counts Africa as its top market and has a long-term agreement with the WHO/United Nations’ Population Fund (UNFPA).

“Globally there is a huge demand for female condoms and it is expected to grow three times in the next five years,” says Omprakash Garg Cupid’s 73-year-old chairman. “We are only the second company in the world to get pre-qualification from WHO for the female condom.”  Female condoms are ten times more expensive than male condoms. Cupid makes about 20 million female condoms a year and is looking to double that soon. (The Female Health Company in Chicago is a key competitor for female condoms. It makes and sells the FC2 Female Condom ,which is FDA approved.)


Share holding Pattern as on 31 .12.2016
No of promoter/share holder No of share %
Promoter and promoter group  4 53,86,800 48.46
Public    11,900 5728200 51.54



Financial result

( Rs.In Cr.) Dec.16 Sept.16 June.16 FY15-16 FY16-17
(9 Months)

Revenue (Total)


22.11 16.24 62.81


Net profit


5.36 3.83 15.93


Share Capital


11.12 11.12 11.12




EPS (In Rs.)


4.83 3.45 14.33


CEPS (In Rs.) 6.24 5.31 3.89



9MFY17 Review (April 1st, 2016 to December 31st, 2016)

.  Total Operating income was Rs.66.72Cr for 9MFY17 as compared to Rs.44.56Cr in the corresponding period of the previous year reflecting an increase of 50%

▪ EBITDA stood at Rs.26.48Cr as compared to Rs.18.13 Cr during the corresponding period of previous year, an increase of 46%

▪ EBITDA Margin was 39.7% for 9MFY17 as compared to 40.7% during the corresponding period of the previous year

▪ Net profit stood at Rs.15.61 Cr for 9MFY17 as compared to Rs.11.32 Cr in the corresponding period of the previous year, an increase of 38%

▪ Basic EPS stood at Rs.14.05 as against Rs.10.18 in the corresponding period of last fiscal


We recommended  for Buy at CMP  Rs.328.70 for one year

with Target of Rs.427 with stop loss Rs.280.


36 Thoughts to “Company Info: CUPID LTD (Buy/Sell/Hold)”

  1. Canada prescription required best place to buy online australia.

Leave a Comment